T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011

NCT03022422 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: TIV
BIOLOGICAL: High-Dose TIV

Sponsor

Stanford University

Collaborators

[object Object]